Your Weekly Dose of News in Pharma, Biotech and Health
Amidst the biotech landscape, widespread layoffs persist, prompting reflections on their implications for the industry's future. Efforts to address diversity in medical illustrations gain momentum through a Nigerian doctor's initiative. Google emerges as a burgeoning force in healthcare innovation. Concerns arise about industry connections to patient advocacy board members and executives. Research proposes novel financing methods for pediatric cancer R&D. The UK allocates substantial investment in 17 biopharma manufacturers. Pharma business development leverages regional expertise, emphasizing equitable access to new medical modalities. In public health, the US government commits $1.4 billion to advance COVID therapies and vaccines. AbbVie elevates awareness about mental health and skin conditions through collaboration with patients, physicians, and a celebrity spokesperson.
Mass Layoffs Continue Across The Biotech Sector. What Does This Mean For Pharma’s Future?
Medical illustrations neglect people with dark skin. A Nigerian doctor-to-be is working to change that
US govt awards $1.4 bln for development of new COVID therapies, vaccines
Google Is Rapidly Becoming A Healthcare Powerhouse
Top Patient Advocacy Orgs Have Industry Ties in Leadership, Study Shows
Researchers suggest new methods to finance pediatric cancer R&D — Nature paper
UK invests $13M+ in 17 biopharma manufacturers
Pharma BD: taking advantage of regional modality expertise
Equitable access to new modalities: from innovation to reimbursement
AbbVie raises awareness around mental health and skin conditions with patients, docs and a celebrity spokesperson
For an overview of previous Weekly Notables, visit our Archive